MCA
LLY icon

Maryland Capital Advisors’s Eli Lilly LLY Stock Holding History

Maryland Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Buy
+2
New +$2.04K ﹤0.01% 236
2025
Q4 		$24.7K Buy
+23
New +$22K 0.01% 171

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Maryland Capital Advisors's LLY Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 2 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #236 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in LLY as recently as Q4 2025.

Maryland Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $24.7K in Q4 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Maryland Capital Advisors held 2 shares of Eli Lilly worth $2.4K as of Q2 2026.
  • Eli Lilly was a new Maryland Capital Advisors position in Q2 2026.
  • Eli Lilly made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #236 holding.
  • Maryland Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Maryland Capital Advisors's Eli Lilly position peaked at $24.7K in Q4 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.